Concepedia

Christopher Dittus

CD

Statistics

Publications

15

Citations

1.1K

H-Index

12

Active since

2004

Affiliations

University of North Carolina at Chapel Hill(Current)

UNC Lineberger Comprehensive Cancer Center

Levine Cancer Institute

Boston Medical Center

Boston University

Christopher Dittus is an author at University of North Carolina at Chapel Hill specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2004–2024

15

Publications

15

Differential Trends in the Intestinal and Diffuse Types of Gastric Carcinoma in the United States, 1973–2000: Increase in the Signet Ring Cell Type

Donald E. Henson, Christopher Dittus, Mamoun Younes et al. · Archives of Pathology & Laboratory Medicine · 2004 · 408 citations

Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

Carlos A. Ramos, Natalie S. Grover, Anne Beaven et al. · Journal of Clinical Oncology · 2020 · 366 citations · Full text

A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma

Peter Martin, Nancy L. Bartlett, Kristie A. Blum et al. · Blood · 2019 · 81 citations · Full text

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium

Talal El Zarif, Amin H. Nassar, Elio Adib et al. · Journal of Clinical Oncology · 2023 · 55 citations · Full text

Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma

Timothy Voorhees, Beibo Zhao, Jorge D. Oldan et al. · Blood Advances · 2021 · 45 citations · Full text

, , +15

1–5 of 15